메뉴 건너뛰기




Volumn 2, Issue , 2008, Pages 491-499

Targeted chemotherapy using a cytotoxic somatostatin conjugate to inhibit tumor growth and metastasis in nude mice

Author keywords

Camptothecin; Metastasis; Somatostatin conjugate; Somatostatin receptor; Tumor growth

Indexed keywords


EID: 78650869781     PISSN: None     EISSN: 11779314     Source Type: Journal    
DOI: 10.4137/cmo.s970     Document Type: Article
Times cited : (38)

References (42)
  • 1
    • 38749120897 scopus 로고    scopus 로고
    • A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel
    • Huh, K.M., Min, H.S., Lee, S.C., Lee, H.G., Kim, S. and Park, K. 2008. A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. Journal of Controlled Release, 126:122-9.
    • (2008) Journal of Controlled Release , vol.126 , pp. 122-129
    • Huh, K.M.1    Min, H.S.2    Lee, S.C.3    Lee, H.G.4    Kim, S.5    Park, K.6
  • 2
    • 38549128788 scopus 로고    scopus 로고
    • Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/ poly(amidoamine) copolymer
    • Bencini, M., Ranucci, E., Ferruti, P., Trotta, F., Donalisio, M., Cornaglia, M. et al. 2008. Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/ poly(amidoamine) copolymer. Journal of Controlled Release, 126:17-25.
    • (2008) Journal of Controlled Release , vol.126 , pp. 17-25
    • Bencini, M.1    Ranucci, E.2    Ferruti, P.3    Trotta, F.4    Donalisio, M.5    Cornaglia, M.6
  • 3
    • 37349075381 scopus 로고    scopus 로고
    • Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel
    • Lee, L.Y., Wang, C.H. and Smith, K.A. 2008. Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel. Journal of Controlled Release, 125:96-106.
    • (2008) Journal of Controlled Release , vol.125 , pp. 96-106
    • Lee, L.Y.1    Wang, C.H.2    Smith, K.A.3
  • 4
    • 37649010361 scopus 로고    scopus 로고
    • Nanoparticles for drug delivery in cancer treatment
    • Haley, B. and Frenkel, E. 2008. Nanoparticles for drug delivery in cancer treatment. Urol. Oncol., 26:57-64.
    • (2008) Urol. Oncol. , vol.26 , pp. 57-64
    • Haley, B.1    Frenkel, E.2
  • 5
    • 1942453805 scopus 로고    scopus 로고
    • Solid lipid nanoparticles for parenteral drug delivery
    • Wissing, S.A., Kayser, O. and Muller, R.H. 2004. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev., 56:1257-72.
    • (2004) Adv. Drug Deliv. Rev. , vol.56 , pp. 1257-1272
    • Wissing, S.A.1    Kayser, O.2    Muller, R.H.3
  • 6
    • 23144456813 scopus 로고    scopus 로고
    • Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
    • Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T. et al. 2005. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature, 436:568-72.
    • (2005) Nature , vol.436 , pp. 568-572
    • Sengupta, S.1    Eavarone, D.2    Capila, I.3    Zhao, G.4    Watson, N.5    Kiziltepe, T.6
  • 7
    • 0035862692 scopus 로고    scopus 로고
    • Taxane-Antibody Conjugates Afford Potent Cytotoxicity, Enhanced Solubility, and Tumor Target Selectivity1
    • Guillemard, V. and Saragovi, H.U. 2001. Taxane-Antibody Conjugates Afford Potent Cytotoxicity, Enhanced Solubility, and Tumor Target Selectivity1. Cancer Res., 61:694-9.
    • (2001) Cancer Res. , vol.61 , pp. 694-699
    • Guillemard, V.1    Saragovi, H.U.2
  • 8
    • 34548630543 scopus 로고    scopus 로고
    • Drug safety evaluation through biomarker analysis-A toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer
    • Hsieh, F.Y., Tengstrand, E., Lee, J.W., Li, L.Y., Silverman, L., Riordan, B. et al. 2007. Drug safety evaluation through biomarker analysis-A toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer. Toxicol. Appl. Pharmacol., 224:12-8.
    • (2007) Toxicol. Appl. Pharmacol , vol.224 , pp. 12-18
    • Hsieh, F.Y.1    Tengstrand, E.2    Lee, J.W.3    Li, L.Y.4    Silverman, L.5    Riordan, B.6
  • 9
    • 4143108331 scopus 로고    scopus 로고
    • Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents
    • Sun, L.C., Fuselier, J.A. and Coy, D.H. 2004. Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents. Drug Deliv., 11:231-8.
    • (2004) Drug Deliv. , vol.11 , pp. 231-238
    • Sun, L.C.1    Fuselier, J.A.2    Coy, D.H.3
  • 10
    • 0035094324 scopus 로고    scopus 로고
    • A targeted cytotoxic somatostatin (SST) analogue, AN.-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice
    • Kiaris, H., Schally, A.V., Nagy, A., Szepeshazi, K., Hebert, F. and Halmos, G. 2001. A targeted cytotoxic somatostatin (SST) analogue, AN.-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice. Eur. J. Cancer, 37:620-8.
    • (2001) Eur. J. Cancer , vol.37 , pp. 620-628
    • Kiaris, H.1    Schally, A.V.2    Nagy, A.3    Szepeshazi, K.4    Hebert, F.5    Halmos, G.6
  • 11
    • 23844456666 scopus 로고    scopus 로고
    • Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells
    • Moody, T.W., Fuselier, J.A., Coy, D.H., Mantey, S., Pradhan, T., Nakagawa, T. et al. 2005. Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells. Peptides, 26:1560-6.
    • (2005) Peptides , vol.26 , pp. 1560-1566
    • Moody, T.W.1    Fuselier, J.A.2    Coy, D.H.3    Mantey, S.4    Pradhan, T.5    Nakagawa, T.6
  • 12
    • 2542477191 scopus 로고    scopus 로고
    • Development of high affinity camptothecinbombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells
    • Moody, T.W., Mantey, S.A., Pradhan, T.K., Schumann, M., Nakagawa, T., Martinez, A. et al. 2004. Development of high affinity camptothecinbombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells. J. Biol. Chem., 279:23580-9.
    • (2004) J. Biol. Chem. , vol.279 , pp. 23580-23589
    • Moody, T.W.1    Mantey, S.A.2    Pradhan, T.K.3    Schumann, M.4    Nakagawa, T.5    Martinez, A.6
  • 13
    • 42449112468 scopus 로고    scopus 로고
    • Cytotoxic conjugates of peptide hormones for cancer chemotherapy
    • Sun, L.C. and Coy, D.H. 2008. Cytotoxic conjugates of peptide hormones for cancer chemotherapy. Drugs of the Future, 33:217-23.
    • (2008) Drugs of the Future , vol.33 , pp. 217-223
    • Sun, L.C.1    Coy, D.H.2
  • 14
    • 0042854927 scopus 로고    scopus 로고
    • Peptide receptors as molecular targets for cancer diagnosis and therapy
    • Reubi, J.C. 2003. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev., 24:389-427.
    • (2003) Endocr. Rev. , vol.24 , pp. 389-427
    • Reubi, J.C.1
  • 15
    • 0034513226 scopus 로고    scopus 로고
    • Molecular and biological determinants of the cytotoxic actions of camptothecins. Perspective for the development of new topoisomerase I inhibitors
    • Kohn, K.W. and Pommier, Y. 2000. Molecular and biological determinants of the cytotoxic actions of camptothecins. Perspective for the development of new topoisomerase I inhibitors. Ann. N.Y. Acad. Sci., 922:11-26.
    • (2000) Ann. N.Y. Acad. Sci. , vol.922 , pp. 11-26
    • Kohn, K.W.1    Pommier, Y.2
  • 16
    • 0032169909 scopus 로고    scopus 로고
    • Camptothecins: A review of their development and schedules of administration
    • O'Leary, J. and Muggia, F.M. 1998. Camptothecins: a review of their development and schedules of administration. Eur. J. Cancer, 34:1500-8.
    • (1998) Eur. J. Cancer , vol.34 , pp. 1500-1508
    • O'Leary, J.1    Muggia, F.M.2
  • 17
    • 33747620735 scopus 로고    scopus 로고
    • In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors
    • Moody, T.W., Sun, L.C., Mantey, S.A., Pradhan, T., Gonzales, N., Coy, D.H. et al. 2006. In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors. J. Pharmacol. Exp. Ther., 318:1265-72.
    • (2006) J. Pharmacol. Exp. Ther. , vol.318 , pp. 1265-1272
    • Moody, T.W.1    Sun, L.C.2    Mantey, S.A.3    Pradhan, T.4    Gonzales, N.5    Coy, D.H.6
  • 18
    • 24644445086 scopus 로고    scopus 로고
    • Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1
    • Engel, J.B., Schally, A.V., Halmos, G., Baker, B., Nagy, A. and Keller, G. 2005. Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1. Cancer, 104:1312-21.
    • (2005) Cancer , vol.104 , pp. 1312-1321
    • Engel, J.B.1    Schally, A.V.2    Halmos, G.3    Baker, B.4    Nagy, A.5    Keller, G.6
  • 19
    • 29144509887 scopus 로고    scopus 로고
    • Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins
    • Engel, J.B., Schally, A.V., Halmos, G., Baker, B., Nagy, A. and Keller, G. 2005. Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins. Endocr. Relat. Cancer., 12:999-1009.
    • (2005) Endocr. Relat. Cancer. , vol.12 , pp. 999-1009
    • Engel, J.B.1    Schally, A.V.2    Halmos, G.3    Baker, B.4    Nagy, A.5    Keller, G.6
  • 20
    • 25144450706 scopus 로고    scopus 로고
    • Receptors for luteinizing hormone releasing hormone (LHRH) expressed in human non-Hodgkin's lymphomas can be targeted for therapy with the cytotoxic LHRH analogue AN-207
    • Keller, G., Schally, A.V., Gaiser, T., Nagy, A., Baker, B., Halmos, G. et al. 2005. Receptors for luteinizing hormone releasing hormone (LHRH) expressed in human non-Hodgkin's lymphomas can be targeted for therapy with the cytotoxic LHRH analogue AN-207. Eur. J. Cancer., 41:2196-202.
    • (2005) Eur. J. Cancer. , vol.41 , pp. 2196-2202
    • Keller, G.1    Schally, A.V.2    Gaiser, T.3    Nagy, A.4    Baker, B.5    Halmos, G.6
  • 21
    • 33745929350 scopus 로고    scopus 로고
    • Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormonereleasing hormone and their combinations
    • Buchholz, S., Keller, G., Schally, A.V., Halmos, G., Hohla, F., Heinrich, E. et al. 2006. Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormonereleasing hormone and their combinations. PNAS, 103:10403-7.
    • (2006) PNAS , vol.103 , pp. 10403-10407
    • Buchholz, S.1    Keller, G.2    Schally, A.V.3    Halmos, G.4    Hohla, F.5    Heinrich, E.6
  • 22
    • 0028035411 scopus 로고
    • Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines
    • Fujita, T., Yamaji, Y., Sato, M., Murao, K. and Takahara, J. 1994. Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines. Life Sci., 55:1797-806.
    • (1994) Life Sci. , vol.55 , pp. 1797-1806
    • Fujita, T.1    Yamaji, Y.2    Sato, M.3    Murao, K.4    Takahara, J.5
  • 23
    • 0028032570 scopus 로고
    • Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity
    • Taylor, J.E., Theveniau, M.A., Bashirzadeh, R., Reisine, T. and Eden, P.A. 1994. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity. Peptides, 15:1229-36.
    • (1994) Peptides , vol.15 , pp. 1229-1236
    • Taylor, J.E.1    Theveniau, M.A.2    Bashirzadeh, R.3    Reisine, T.4    Eden, P.A.5
  • 24
    • 0032893138 scopus 로고    scopus 로고
    • Expression of somatostatin receptors in peritumoral veins of human tumors
    • Denzler, B. and Reubi, J.C. 1999. Expression of somatostatin receptors in peritumoral veins of human tumors. Cancer, 85:188-98.
    • (1999) Cancer , vol.85 , pp. 188-198
    • Denzler, B.1    Reubi, J.C.2
  • 25
    • 33845650679 scopus 로고    scopus 로고
    • A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9
    • Sun, L.C., Luo, J., Mackey, L.V., Fuselier, J.A. and Coy, D.H. 2007. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Let., 246:157-66.
    • (2007) Cancer Let. , vol.246 , pp. 157-166
    • Sun, L.C.1    Luo, J.2    McKey, L.V.3    Fuselier, J.A.4    Coy, D.H.5
  • 26
    • 1842741030 scopus 로고    scopus 로고
    • Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design
    • Sun, L.C., Vasilevich, N.I., Fuselier, J.A., Hocart, S.J. and Coy, D.H. 2004. Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design. Bioorg. Med. Chem. Lett, 14:2041-6.
    • (2004) Bioorg. Med. Chem. Lett , vol.14 , pp. 2041-2046
    • Sun, L.C.1    Vasilevich, N.I.2    Fuselier, J.A.3    Hocart, S.J.4    Coy, D.H.5
  • 27
    • 0032545948 scopus 로고    scopus 로고
    • Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes
    • Pradhan, T.K., Katsuno, T., Taylor, J.E., Kim, S.H., Ryan, R.R., Mantey, S.A. et al. 1998. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. Eur. J. Pharmacol., 343:275-87.
    • (1998) Eur. J. Pharmacol. , vol.343 , pp. 275-287
    • Pradhan, T.K.1    Katsuno, T.2    Taylor, J.E.3    Kim, S.H.4    Ryan, R.R.5    Mantey, S.A.6
  • 28
    • 11244347812 scopus 로고    scopus 로고
    • Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7
    • Liu, C., Chen, J., Kuei, C., Sutton, S., Nepomuceno, D., Bonaventure, P. et al. 2005. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol. Pharmacol., 67:231-40.
    • (2005) Mol. Pharmacol. , vol.67 , pp. 231-240
    • Liu, C.1    Chen, J.2    Kuei, C.3    Sutton, S.4    Nepomuceno, D.5    Bonaventure, P.6
  • 29
    • 2342509665 scopus 로고    scopus 로고
    • The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs
    • Anthony, C.T., Hughey, S., Lyons, J., Weiss, S., Hornick, C.A., Drouant, G.J. et al. 2004. The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs. J. Surg. Res., 119:1-13.
    • (2004) J. Surg. Res. , vol.119 , pp. 1-13
    • Anthony, C.T.1    Hughey, S.2    Lyons, J.3    Weiss, S.4    Hornick, C.A.5    Drouant, G.J.6
  • 30
    • 0028888586 scopus 로고
    • Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors
    • Panetta, R. and Patel, Y.C. 1995. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sciences, 56:333-42.
    • (1995) Life Sciences , vol.56 , pp. 333-342
    • Panetta, R.1    Patel, Y.C.2
  • 32
    • 0034934877 scopus 로고    scopus 로고
    • Growing vascular endothelial cells express somatostatin subtype 2 receptors
    • Watson, J.C., Balster, D.A. and Gebhardt, M.B. 2001. Growing vascular endothelial cells express somatostatin subtype 2 receptors. Br. J. Cancer, 85:266-72.
    • (2001) Br. J. Cancer , vol.85 , pp. 266-272
    • Watson, J.C.1    Balster, D.A.2    Gebhardt, M.B.3
  • 33
    • 0034803184 scopus 로고    scopus 로고
    • Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers
    • Szepeshazi, K., Schally, A.V., Halmos, G., Sun, B., Hebert, F., Csernus, B. et al. 2001. Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers. Clin. Cancer Res., 7:2854-61.
    • (2001) Clin. Cancer Res. , vol.7 , pp. 2854-2861
    • Szepeshazi, K.1    Schally, A.V.2    Halmos, G.3    Sun, B.4    Hebert, F.5    Csernus, B.6
  • 34
    • 0032539609 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
    • Nagy, A., Schally, A.V. and Halmos, G. 1998. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. PNAS, 95:1794-9.
    • (1998) PNAS , vol.95 , pp. 1794-1799
    • Nagy, A.1    Schally, A.V.2    Halmos, G.3
  • 35
    • 33846703621 scopus 로고    scopus 로고
    • Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector
    • Sun, L.C., Luo, J., Mackey, L.V., Fuselier, J.A. and Coy, D.H. 2007. Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector. Anticancer Drugs, 18:341-8.
    • (2007) Anticancer Drugs , vol.18 , pp. 341-348
    • Sun, L.C.1    Luo, J.2    McKey, L.V.3    Fuselier, J.A.4    Coy, D.H.5
  • 36
    • 17144397158 scopus 로고    scopus 로고
    • Study of inhibitory effects of an antiangiogenic somatostatin-camptothecin conjugate on laser-induced choroidal neovascularization in rats
    • Bezerra, Y., Fuselier, J.A., Peyman, G.A., Oner, H., Drouant, G. and Coy, D.H. 2005. Study of inhibitory effects of an antiangiogenic somatostatin-camptothecin conjugate on laser-induced choroidal neovascularization in rats. Retina, 25:345-54.
    • (2005) Retina , vol.25 , pp. 345-354
    • Bezerra, Y.1    Fuselier, J.A.2    Peyman, G.A.3    Oner, H.4    Drouant, G.5    Coy, D.H.6
  • 37
    • 34548504526 scopus 로고    scopus 로고
    • Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells
    • Moody, T.W., Mantey, S.A., Fuselier, J.A., Coy, D.H. and Jensen, R.T. 2007. Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells. Peptides, 28:1883-90.
    • (2007) Peptides , vol.28 , pp. 1883-1890
    • Moody, T.W.1    Mantey, S.A.2    Fuselier, J.A.3    Coy, D.H.4    Jensen, R.T.5
  • 40
    • 0028906832 scopus 로고
    • Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate
    • Qin, Y., Ertl, T., Groot, K., Horvath, J., Cai, R.Z. and Schally, A.V. 1995. Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate. Int. J. Cancer, 60:694-700.
    • (1995) Int. J. Cancer , vol.60 , pp. 694-700
    • Qin, Y.1    Ertl, T.2    Groot, K.3    Horvath, J.4    Cai, R.Z.5    Schally, A.V.6
  • 41
    • 0025861592 scopus 로고
    • Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth
    • Evers, B.M., Townsend, Jr. C.M., Upp, J.R., Allen, E., Hurlbut, S.C., Kim, S.W. et al. 1991. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology, 101:303-11.
    • (1991) Gastroenterology , vol.101 , pp. 303-311
    • Evers, B.M.1    Townsend, C.M.2    Upp, J.R.3    Allen, E.4    Hurlbut, S.C.5    Kim, S.W.6
  • 42
    • 7944236863 scopus 로고    scopus 로고
    • Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells
    • Ludvigsen, E., Stridsberg, M., Taylor, J.E., Culler, M.D., Oberg, K. and Janson, E.T. 2004. Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells. Med. Oncol., 21:285-95.
    • (2004) Med. Oncol. , vol.21 , pp. 285-295
    • Ludvigsen, E.1    Stridsberg, M.2    Taylor, J.E.3    Culler, M.D.4    Oberg, K.5    Janson, E.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.